NDC Code(s) : 0002-7140-01
Packager : Eli Lilly and Company

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

REOPROabciximab INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0002-7140
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
abciximab(UNII: X85G7936GV)
(abciximab - UNII:X85G7936GV) 		abciximab2 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
sodium phosphate(UNII: SE337SVY37)
sodium chloride(UNII: 451W47IQ8X)
polysorbate 80(UNII: 6OZP39ZG8H)
water(UNII: 059QF0KO0R)
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0002-7140-015 mL in 1 VIAL, SINGLE-USE Type 0: Not a Combination Product16/12/1993
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA103575 12/16/1993 01/31/2019

PRINCIPAL DISPLAY PANEL

NDC 0002-7140-01

ABCIXIMAB
REOPRO®

10 mg/5 mL vial

Sterile Solution
No Preservatives

1 VIAL
No. VL7140

Rx only

PRINCIPAL DISPLAY PANEL - 10 mg/5 mL Vial Carton